Qishen Taohong Granules

Qishen Taohong Granules (芪参桃红颗粒) is a traditional Chinese medicine (TCM) compound formulation used primarily as an adjunct therapy for chronic heart failure (CHF). It is administered orally in granule form. Clinical studies have shown that, when added to standard CHF treatment, it can improve cardiac function as measured by the New York Heart Association (NYHA) classification and quality of life scores. Patients receiving Qishen Taohong Granules demonstrated improvements in exercise capacity (6-minute walk test), symptom relief (shortness of breath, fatigue, edema), and reductions in N-terminal pro-B-type natriuretic peptide (NT-proBNP), a biomarker for heart failure severity[1][5][6]. The mechanism of action is believed to involve multi-target modulation typical of TCM formulas—potentially improving energy metabolism and alleviating symptoms associated with qi deficiency and blood stasis—but specific molecular targets are not well defined[1]. No significant adverse effects were reported in clinical trials.

Brand names

Qishen Taohong Granules

Other names

芪参桃红颗粒QTG